Power Systems for Implantable Pacemakers, Cardioverters, and Defibrillators

Published on 21/06/2015 by admin

Filed under Cardiovascular

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2460 times

6 Power Systems for Implantable Pacemakers, Cardioverters, and Defibrillators

This chapter discusses batteries and capacitors used to power pacemakers, defibrillators, and similar implantable devices. Batteries are active components that convert chemical energy into electrical energy. Capacitors are passive and temporarily store energy, often to increase the available power (rate of energy delivery) in an electric circuit. This chapter provides practical information to help physicians manage patients who have implanted medical devices that require electrical power.

The battery is conceptually different from the other components of an implantable medical device. In principle, the other components are designed to last indefinitely. However, for current cardiac devices such as pacemakers and defibrillators, the available chemical energy of the battery is consumed during its use. Eventually, the output of the battery becomes insufficient to operate the electronics and must be replaced. At present, batteries for implantable cardiac devices are part of the device, and the entire pulse generator must be replaced to renew the battery. However, this is not true of all implantable pulse generators. Many neurologic stimulators now use rechargeable batteries. In the future, more implantable devices may also use rechargeable batteries so that the energy powering the device can be renewed.

While batteries transform chemical energy into electrical energy, capacitors act as energy storage devices. Capacitors that intermittently boost the power capability of electronic circuits are of principal interest here. The large capacitors in an implantable cardioverter-defibrillator (ICD) allow the device to deliver a therapeutic, high-voltage, high-energy shock to the heart over a few milliseconds, which the battery itself could not do. Understanding the properties and limitations of the components used to power implantable devices will help physicians not only better understand the devices, but also deliver the best care to their patients.

image Batteries

Basic Function and Electrochemistry

Major Components Of Batteries

Figure 6-1 shows a simple battery; the major parts are the anode, cathode, and electrolyte. The anode and cathode must be physically separated, and both must be in contact with the electrolyte.

Functional Characteristics Of Batteries

Cell Voltage and Current

The open-circuit voltage of a battery can be calculated from the thermodynamic free energy for the discharge reaction. This is the voltage that will be measured when there are no kinetic limitations, a condition that occurs only when an insignificant amount of current is being drawn from the battery. With the onset of current flow, the voltage at the battery terminals will be smaller than the open-circuit value. Both chemistry and battery design determine the relationship between voltage and current drawn from the battery. For example, a lead-acid battery for automotive use is constructed of very conductive materials and is designed with large-surface-area electrodes so that extremely high currents can be drawn from it to run an engine’s starter motor. On the other hand, a transistor radio battery is designed with small electrodes because relatively low currents are typically needed to power small portable electronic devices. Figure 6-2 shows a typical current-voltage relationship in which the load voltage approaches the open-circuit voltage (OCV) as the current approaches zero. At the other extreme, the maximum (short-circuit) current is observed when the load voltage approaches zero.

Internal Resistance and Impedance

Electrical impedance and resistance are important battery properties that play a significant role in the clinical performance of many implantable devices. The terms impedance and resistance are often used interchangeably but are not the same. Both are terms for the change in voltage per unit change in current in an electric circuit, but they are measured under different conditions. Impedance is the more general term, encompassing effects of resistance, capacitance, inductance, and other circuit elements on the relationship between voltage and current. The resistive component of impedance is measured using direct-current methods. Alternating-current and transient methods are used to measure the additional components of impedance besides resistance.

For simple, resistive electric circuit elements, Ohm’s law, V = IR, accurately describes a linear relationship between voltage drop, V, and the corresponding change in current, I, with resistance, R, as the proportionality constant. However, a battery is a complex electrochemical device with several nonlinear processes operating in series/parallel combinations. Different processes may dominate at different current levels, depths of discharge, and time. Consequently, the relationship between current and voltage for a battery is, in general, nonlinear, even at very low currents. Although this relationship is sometimes characterized by a quantity called RDC, Ohm’s law should only be applied to batteries with caution.

Non-Ideal Battery Behavior

In addition to the principles and the nomenclature of battery operation, it is also important to understand factors that limit a battery’s ability to power an implantable device.

Polarization

Polarization is any process that causes the voltage at the terminals of a battery to drop below its open-circuit value when it is providing current. The internal resistance of the battery is one important cause. This is well illustrated in Figure 6-3 for the lithium/iodine battery, but the same is true for all batteries to some degree. The differences in the curves for discharge voltage versus capacity at four rates of constant current discharge are mainly caused by the voltage drop associated with internal resistance of the battery. Other contributing elements of voltage loss when a battery provides current are concentration polarization, which is associated with concentration gradients that may develop in the electrolyte or the active electrode materials, and activation polarization, which is associated with the kinetics of the electron-transfer reactions at the electrode/electrolyte interfaces.

When current is drawn from a battery, all these processes occur to some extent. The net effect of these kinetic limitations is always observed as a decrease in the voltage at the terminals of the battery. In general, neither concentration polarization nor electron-transfer polarization conforms to Ohm’s law.

Batteries in Implantable Cardiac Rhythm Management Devices

Power Requirements

An important parameter for a device is the peak power requirement. For example, the rate of energy consumption differs greatly for pacemakers and defibrillators. Pacemakers use very small amounts of energy when they stimulate the heart, on the order of 15 µJ. Defibrillators, on the other hand, deliver as much 40 J for a defibrillation shock. A battery optimized for a pacemaker could never come close to supplying energy at the rate required to power a defibrillator. Likewise, a defibrillator battery is not an optimum choice to power a pacemaker, although it could easily supply the current needed. The high-power design of a defibrillator battery has a significantly lower energy density than that of a pacemaker battery, by a factor of as much as two. Thus, if a defibrillator battery was used primarily for pacing, and everything else were equal, it would need to be twice as large as an optimized pacemaker battery to obtain the same longevity.

Optimizing a battery for longevity and power becomes more complicated when a device performs multiple functions, such as both bradycardia pacing and defibrillation. For example, up to now, the lithium/iodine battery has been the dominant power source for implantable cardiac pacemakers, which typically have peak power demands of 100 to 200 µW. Under these conditions, the lithium/iodine battery, which is still used in many pacemakers, can maintain an adequate voltage, even when its internal resistance reaches several thousand ohms. On the other hand, an implantable cardiac defibrillator may have peak power requirements approximately 10,000 times greater than those of a pacemaker. Under such a high power demand, the voltage of an Li/I2 battery would drop to almost zero, and the power delivered to the device would be almost nil.

In recent years the distinction between a need for high-rate and low-rate batteries has become more blurred because features such as distance (“wireless”) telemetry and multisite pacing need both more current and more capacity to operate. The result is that battery designers have been challenged to develop medium-rate batteries that can deliver more power than pacemaker batteries of the past while still having a high energy density.

Size, Energy Density, and Current Drain

The relationship between battery size and average current is not one of direct proportionality. For example, decreasing the average current by 50% will not permit a 50% reduction in battery size without compromising longevity because of the inactive materials in a battery (e.g., case, electrolyte, current collectors). Likewise, the usable energy density is also a function of the current demand on the cell. As the current from the cell is increased, the resulting voltage drops significantly (see Fig. 6-3), which reduces the time during which the cell can provide current at or above the minimum voltage necessary to operate the electronic circuits. Thus, usable energy density, which is directly proportional to the area under the discharge (voltage vs. capacity) curve, is also reduced. For very-high-rate batteries such as those used to power ICDs, this is not such an issue because their internal resistance is extremely low.

The Battery and Longevity of Pulse Generator

Longevity is typically defined as the interval between device implantation and detection of the end-of-service indicator. Because therapy can vary substantially from patient to patient, the longevity requirement is typically linked to a specified set of nominal conditions and programmed parameters. The minimum battery capacity required to achieve the specified longevity can be calculated from the average current needed for this nominal set of conditions. The following equation relates the longevity of the pulse generator, L, to the deliverable capacity of the battery, Qdel, and the average pacing current, I:

(6-5) image

The unit of L is years, Qdel is in milliampere-hours (mA-hr), and I in milliamperes (mA). The conversion factor 8766 (365.25 days/yr × 24 hours/day) is needed because longevity is expressed in years, not hours.

The actual capacity that is built into the battery must be larger than Qdel, because additional capacity is needed to account for self-discharge and other parasitic losses of capacity (Qsd). More capacity must also be included to allow for an interval between the end-of-service indicator and the time when the battery can no longer power the device (QEOL). The total capacity (QTotal) is defined as follows:

image

The average current drain in Equation 6-5 depends on the characteristic of the pulse generator circuitry and the requirements for therapy. It has two main components: the static current drain, which powers the electronic components even when no therapy is delivered, and the therapeutic current. The trend throughout the evolution of implantable devices has been that current demands decrease as technology is improved, which leads to smaller batteries and pulse generators while maintaining relatively constant longevity. Some expect that this trend will continue, but the path to lower current often has a sawtooth profile because new features and therapeutic modalities temporarily increase the required current. For ICDs, the situation is more complicated because of the unpredictable mixture of bradycardia and tachyarrhythmia therapy delivery and the constant need to have a very high power capability in any device that may be required to deliver a defibrillation shock quickly.

Effect of Pulse Width on Pacing Current

Increasing the pacing rate, pulse width, or pulse amplitude increases the average pacing current. The average pacing current, excluding static current, is directly proportional to the pacing rate. Recall that the pacing pulse results from the discharge of a capacitor through the electrode-heart interface. This capacitor produces a pulse in which the current decays exponentially with time, as shown for two different pulse widths in Figure 6-4.

Thus, the time-dependent behavior of the current during the pacing pulse is given by the following equation:

(6-7) image

where VA is the amplitude at the beginning of the pacing pulse, RH is the impedance of the lead plus the heart (discussed later), C is the value of the capacitor that delivers the pacing pulse, and t is the time since the beginning of the pacing pulse. In Figure 6-4, A and B, the pulse width is tw and tw/2, respectively. The area under each current-time curve gives the total charge delivered during the pulse. Although the width of the pulse in B is half that of the pulse in A, the charge delivered by this pulse is considerably more than half that of the longer pulse. The exact ratio of the charge delivered in the two cases depends on the values of RH and C. Nevertheless, reducing the pulse width by a given fraction will always reduce the average pacing current by a substantially smaller fraction because of the exponentially decaying shape of the pacing stimulus current curve.

Effect of Pulse Amplitude on Pacing Current

The definition of pacing pulse amplitude may vary somewhat between manufacturers of implantable pulse generators. For our purposes, pulse amplitude is defined as the voltage delivered to the heart at the beginning of the pacing pulse (“leading edge” voltage). As stated earlier, the area under the current-time curve gives the charge delivered per pulse. Thus, doubling the amplitude doubles the current and the total charge delivered to the heart. Also, because the charge per pulse is doubled, it might seem that the average pacing current drawn from the battery would also be doubled. However, the impact on the pacing current is much larger than that, as seen from the following argument. The energy per pacing pulse is defined as follows:

(6-8) image

In Equation 6-8, VA is the average pacing stimulus output voltage of the pulse generator, IA is the average pacing current delivered to the heart, and tw is the pulse width. If we consider the lead-electrode-heart interface to be mainly resistive, Ohm’s law, I = V/R, can be substituted in Equation 6-8, which becomes the following:

(6-9) image

In Equation 6-9, RH is the effective ohmic load of the heart and lead. From this equation it is readily apparent that energy consumption increases with the square of the output voltage. The effect of this energy increase on the current drawn from the battery may not be intuitive. Because the battery supplies all the energy delivered to the heart at a relatively constant voltage, any increase in energy is accompanied by a proportional increase in current drawn from the battery. Thus the average pacing current is increased by a factor of four if VA is doubled. In fact, this is the best situation; additional energy losses occur when the stimulus voltage is programmed to a higher level because the electronic circuit for increasing the stimulus voltage is not 100% efficient.

Effect of Lead Impedance on Pacing Current

It is also important to consider the effect of RH on the average pacing current. RH is sometimes called “lead impedance,” but this is a misnomer. The impedance of the lead, itself, is mainly a resistance and it is relatively small (50-100 ohms). Most of the “lead” impedance actually arises at the electrode-tissue interface (500-1000 ohms or more). The factors affecting the impedance of this interface are discussed in Chapter 1. In general, the average pacing current is approximately inversely proportional to the sum of the actual lead and tissue interface impedances. Thus, there is a substantial interest in technologies that can increase RH at the electrode-tissue interface (without increasing the lead conductor resistance), thereby decreasing the pacing current while maintaining a constant or even reduced pacing threshold voltage.

Battery End-of-Service Indication

End-of-service requirements result from the need to indicate impending battery depletion in both pacemakers and defibrillators in a manner that allows adequate time to replace the device. In general, this requires a battery to have some measurable characteristic, such as voltage or impedance, which can be related to its state of discharge. The pulse generator end-of-service indication must occur well before the battery loses so much voltage that it cannot sustain cardiac pacing or perform defibrillation. Because longevity is a strong function of device settings, the longevity requirement is typically linked to a specific set of nominal pacing or defibrillation parameters. A detailed knowledge of the variations in battery performance, the changes in load current with pulse generator settings, and the accuracy of the end-of-service measurement circuitry is necessary to ensure that these requirements will be met.

Methods for Monitoring State of Battery Discharge

Battery Voltage

The most common method to indicate impending battery depletion is to measure the battery voltage. Most modern devices incorporate a voltage measurement circuit in the form of an analog-to-digital converter. The digitized battery voltage can be compared with a value stored in a nonvolatile memory to trigger the ERI, or it can be telemetered to the programmer where the comparison is made.

For lithium/iodine batteries, the battery voltage remains relatively constant throughout most of its discharge under low load conditions, as shown in the voltage versus capacity curve in Figure 6-5. This figure also shows the resistance of this battery as it discharges. Note that the resistance changes from a modest value at the beginning of service to a quite large value when it is almost depleted.

Because the battery voltage is relatively constant for much of the pulse generator’s useful life, the telemetered voltage of this battery may not be particularly useful for estimating remaining service. Voltage characteristics during discharge differ for different battery chemistries, so clinicians should not assume familiarity with one model or that one type of battery can be applied to another. For example, the lithium/iodine battery has a fairly flat discharge curve throughout most of its life at pacing currents. However, other battery chemistries have voltage characteristics much different than Li/I2. The lithium/silver vanadium oxide (Li/SVO) battery used in many ICDs has two distinct voltage regions before the typical ERI voltage. The region following the second plateau is sloped. The switch to the sloped discharge region can be used as the ERI trigger for this battery chemistry. This voltage is much less sensitive to current variances than the voltage chosen for an Li/I2 battery because the internal resistance of the Li/SVO battery is much lower than the Li/I2, so for the Li/SVO system, voltage is a good indicator of remaining service life.

Battery Impedance

Battery impedance is another parameter used to signal the elective replacement point. Battery impedance is generally much less dependent on current than battery voltage and may convey more information about the battery’s state of discharge. For example, although the voltage of an Li/I2 battery remains relatively constant through most of its discharge, its impedance increases continuously, and especially rapidly as the battery approaches depletion (see Fig. 6-5). At depletion, battery impedance is not only useful for signaling the elective replacement point but may also provide an estimate of remaining service life. This feature has been incorporated into some pacemaker designs. Battery impedance is usually determined from the open-circuit and load-circuit voltages (or two different load-circuit voltages) of the battery by measuring the voltage drop across a known resistor within the pulse generator, then assuming Ohm’s law can be applied.

False Triggering

Any large increase in average battery current, even if temporary, in pulse generators that utilize battery voltage to indicate the elective replacement point may drop the battery voltage below the ERI trigger value before the true ERI point is reached; this occurs particularly with the Li/I2 battery because of its high resistance. For example, changes in current can result from electrophysiologic studies with noninvasively programmed stimulation (NIPS) in which the pacemaker is used to interrupt an episode of tachycardia by delivering short bursts of very-high-rate pacing, or from high pacing rates or telemetry sessions. Because ERI is usually latched (stored) when it is triggered, these temporary increases in current can cause a false, premature appearance of the ERI. In most cases, devices are designed to allow an ERI prematurely triggered to be reset. In some devices, ERI is inhibited during temporary high-current events to prevent false triggers.

In ICDs, ERI is usually based on the battery voltage or the time required to charge the capacitor. The battery voltage is usually measured during normal sensing/pacing operation and not during a defibrillation therapy, when the battery voltage is depressed. Because of the very low internal resistance of ICD batteries, pacing parameters have a much smaller effect on triggering ERI in these devices, so false triggering is less of a problem. Alternatively, some ICDs base ERI determination on the time required to charge the output capacitor. This approach is possible because most battery designs have a reduced power capability as the battery approaches depletion. This method does not usually cause false ERI triggering.

Battery Chemistries Used in Pacemakers

Lithium/Iodine Battery

The lithium/iodine battery is probably the most well known implantable battery because it has been used in the vast majority of cardiac pacemakers. The first implant of a pacemaker powered by an Li/I2 occurred in 1972.5,6,9 At least 13 million Li/I2-powered pacemakers have now been implanted. Many factors favor the use of this battery system. When the current demand is low, it is difficult to improve on the performance of Li/I2 batteries; their high energy density and low rate of self-discharge result in good longevity and small size. The inherently high impedance of the Li/I2 battery has not been a major disadvantage up to now because the current required by modern pacemaker circuits is low, typically about 10 µA. Note that the much larger current delivered during a (short duration) pacing pulse is drawn from a capacitor, which can charge between pacing pulses. The voltage and impedance characteristics of the Li/I2 cell also allow the clinician to monitor the approaching end-of-service indication. This battery system is simple, elegant in concept and is inherently resistant to many common modes of failure, as will be discussed below. As a result, Li/I2 batteries have attained a record of reliability unsurpassed among electrochemical power sources.

Cell Structure

Figure 6-6 shows a cutaway view of a typical Li/I2 battery. In general, Li/I2 batteries have a single, central lithium anode that is surrounded by cathode material, which is at least 96% iodine and has been thermally reacted with a polymer material to render a conductive mixture. The central anode is seen with an embedded current collector wire, and the iodine cathode fills much of the volume inside the battery. Figure 6-6 also shows several other important structures, including the electrical feedthrough that connects the anode to the outside of the cell. The case serves as the site of the electrical connection to the cathode, which is in direct contact with the inside of the container. Another visible feature is the fill port, the means by which the cathode mixture is introduced into the cell, after which the fill port is hermetically sealed.

Discharge Curve

Figure 6-5 shows the characteristic shapes of the voltage and resistance curves as a function of discharge for a typical Li/I2 battery. During most of the battery life, the voltage is stable near 2.8 V, and the resistance change is gradual and dominated by the growing electrolyte (LiI) thickness. Near the end of battery life, the cathode resistance rapidly dominates the resistance of the cell, as the cathode becomes lower in iodine content and less conductive. The region of discharge dominated by cathode resistance and declining cell voltage is used to signal the approaching “end of service” for most pacemakers powered by Li/I2 batteries.10

Effects of Current Drain on Deliverable Capacity

Unfortunately, the high energy density of the Li/I2 battery may be negated if the application requires frequent periods of high current drain. This is caused by the high internal resistance of the battery, which results in voltage losses due to polarization (see Figs. 6-2 and 6-3). The Li/I2 battery system provided small, simple, highly reliable power sources with power characteristics almost ideally suited to the requirements of cardiac pacing for more than 3 decades. In the late 1990s, however, several device features that required higher power began to emerge. In many cases, these peak power requirements are beyond the capability of Li/I2 batteries. These new features include increased use of addressable memory to capture and store information about the electrical activity of the heart, the need for faster and longer-range telemetry to transmit this information outside the body, new physiologic sensors, and new therapies with higher power requirements, such as cardiac resynchronization and treatment of atrial fibrillation. These higher-power features are now being supported by new battery chemistries with similar energy density to lithium/iodine, but a much higher power capability.

Lithium/Hybrid Cathode Battery

New lithium battery chemistry with a cathode consisting of silver vanadium oxide (SVO) plus CFx has been developed to meet the needs of implantable devices with higher rate therapies and features.11,12 SVO has high power capability and is the same cathode material used to power ICDs. As previously described, CFx has modest power capability and more abrupt end-of-service characteristics, but a very high capacity. The blend of the two cathode materials, called a hybrid cathode, yields a primary battery that has an energy density equal to that of a lithium/iodine battery with approximately 100 times more power capability. It can support the new device features and also has good end-of-service detection because of the SVO. Hybrid cathode batteries have been used in implantable cardiac devices since 1999. Cumulative implants through 2009 total about 300,000.

Plots of voltage versus percent of discharged capacity for SVO and CFx batteries are shown in Figure 6-7, A and B. The voltage curve of hybrid cathode behaves like a superposition of the two in proportion to the starting composition of the mixture (Fig. 6-7, C).

The composition of the hybrid can be chosen based on the application, enhancing the capacity with a greater proportion of CFx or enhancing the power capability and end-of-service characteristics with more SVO. For low- and medium-rate applications, the composition can be chosen such that 85% to 90% of the battery capacity comes from CFx. In this composition range, efficiently designed medium-rate hybrid cathode batteries can match lithium/iodine in energy density at about 1 W-hr/cm3.

Two basic hybrid cathode battery designs have been used in implantable pacemakers. Both types use lithium anodes, a porous polymer separator, a porous pressed-powder cathode pellet, and a liquid electrolyte of lithium salt dissolved in an organic solvent blend. The differences in the two designs are related to the construction of the cathode pellet, either a mixture of the SVO and CFx active materials or the CFx and SVO in separate layers, with the SVO layer adjacent to the lithium anode. In both cases the cathodes also contain a polymer binder and carbon as a conductivity enhancer. Although the methods of construction are different, the discharge behavior of either design is similar to that in Figure 6-7, C.

Battery Chemistries Used in Defibrillators

Comparison of Pacemaker and Defibrillator Batteries

Implantable defibrillators deliver up to 40 J of energy to the heart within a few milliseconds. By contrast, the energy required to stimulate the heart in bradycardia pacing is 1 to 10 µJ over 1 msec or less. Clearly, the demands placed on the battery that powers an implantable defibrillator are much different from those of a battery that powers a bradycardia pacemaker. Implantable defibrillators are designed to deliver a shock within about 10 seconds after the fibrillation or tachycardia is detected. When the ICD determines that a shock may be required, it begins to charge a high-voltage capacitor (discussed later). The time needed to charge the capacitors before the shock is delivered depends on the ability of the battery to sustain a very high current during this period. Thus the implantable defibrillator requires a battery with high peak power, where power is the product of current and voltage (P = I × V).

The high power required of defibrillator batteries dictates a different design than used for pacemaker batteries. Figure 6-6 shows a cutaway view of a typical battery used to power a pacemaker, with small and rather thick electrodes. Contrast this with Figure 6-8, which shows an analogous cutaway for a typical defibrillator battery, with very different construction. The long, thin anode and cathode, with two layers of separator film in between, are rolled into a flattened coil. Alternatively, either or both of the electrodes of ICD batteries can be individual flat-plate electrodes electrically connected to each other. Either method provides the high-power electrode area necessary for ICD batteries. The electrolyte in the defibrillator battery is a highly conductive solution of a lithium salt in organic solvents. The design with large, thin electrodes and liquid electrolyte gives the defibrillator battery the high power needed for quickly charging the high-voltage capacitors in the defibrillator. As mentioned, however, these same characteristics also reduce the energy density of the battery.

Types of Batteries Used in Icds

Three different types of battery chemistries are in use currently in ICDs: lithium/silver vanadium oxide, lithium/manganese dioxide, and lithium/layered SVO-CFx (also called “dual cathode”). The shapes of the discharge curves, resistance of the battery, and effects of time since implant vary among battery types. Regardless of the battery chemistry, all ICD batteries are used in much the same way. Most of the time the battery delivers a low current drain as required for sensing and pacing, which has negligible effect on the battery voltage. When it is necessary to charge the high-voltage capacitors, whether for capacitor formation (see Capacitors) or to deliver a therapeutic shock, the voltage drops quickly by about 1 V, then, after the capacitors are charged, recovers quickly to near the previous value (Fig. 6-9).

Lithium/Silver Vanadium Oxide

The first ICD battery chemistry put into widespread use was Li/SVO.1117 These batteries have a distinctive discharge curve, with a slightly sloping voltage at about 3 V in the first third of discharge, followed by a decline in voltage to a flat region with about 2.6 V, and ending in a short region of declining voltage, as seen in Figure 6-10. The uppermost curve represents the battery voltage during normal sensing and bradycardia pacing operations (also called the “background” voltage). It is this background voltage that is typically monitored by the ICD and reported via telemetry. The “load” voltage is the voltage measured during charging of the defibrillation capacitors, and it is typically much lower than the background voltage.

After many years of laboratory testing and experience in the field, it is apparent that the performance of Li/SVO batteries depends on how rapidly the battery is depleted. When the battery is depleted over a longer period, its internal impedance is higher in the latter half of the discharge curve. Figure 6-11 illustrates this phenomenon, with background voltage and internal impedance of Li/SVO batteries discharged over 3, 5, and 7 years. The internal impedance is unaffected by the discharge rate until midway through discharge. After that point the internal impedance always increases, but to a larger degree for slower discharge rates (i.e., longer discharge times). The higher internal resistance results in longer charge times, especially for the longest discharge periods.

Charge Time–Optimized Li/SVO ICD Batteries

One manufacturer has addressed the problem of the time-dependent increase in charge time by changing the ratio of anode to cathode material in the battery. The first Li/SVO batteries were made with an excess of lithium anode material so that the voltage only dropped slowly at the end of service life. “Cathode limitation” is the most efficient battery design if the goal is to optimize energy density. However, if the goal is to maintain a low charge time, it makes sense to use only part of the cathode capacity, ending the discharge partway onto the 2.6-V plateau where the charge time starts to increase. This is accomplished by reducing the amount of anode and increasing the amount of SVO cathode. As a result, the battery always remains in the region where internal impedance is low and charge times are short.

Figure 6-12 compares the voltage and charge time of conventional SVO ICD batteries with charge time–optimized batteries that occupy the same volume in an ICD. For example, when discharged over 7 years, the charge time is considerably lower starting after 4 years for the charge time–optimized battery than the conventionally balanced battery (Fig. 6-12, A). The charge time–optimized battery maintains a much lower charge time in the latter half of ICD life, without substantially sacrificing longevity.18 The difference in charge time is much less when the battery is depleted over a shorter time, such as 3 years (Fig. 6-12, B).

Lithium/Manganese Dioxide

Another ICD manufacturer uses manganese dioxide batteries for use in ICDs. Lithium/manganese dioxide (Li/MnO2) batteries have been used in consumer and military batteries since the 1980s. For example, high-power Li/MnO2 batteries used for photoflash applications have similar electrical characteristics to those used in ICDs. Figure 6-13 provides a graph of Li/MnO2 battery performance. During the first half of battery life, the voltage remains almost constant at 3.1 V. In the second half of battery life, the voltage gradually slopes downward. This characteristic of the battery voltage, along with charge time and the amount of battery energy consumed, allows the clinician to judge how much longer the battery may last. The internal resistance and thus the charge time of Li/MnO2 batteries remain relatively constant until battery replacement is indicated by the ICD.19

Lithium/Layered Silver Vanadium Oxide–Carbon Monofluoride

Another manufacturer of ICD batteries has combined the properties of two cathode materials, silver vanadium oxide and carbon monofluoride, to create a novel ICD battery that exploits the best features of those two materials. SVO provides high power while CFx contributes high capacity per unit volume. The construction of the cathode portion of the battery is rather complex, with a central CFx cathode sandwiched between two metallic current collectors, with SVO electrodes on each side. This arrangement of electrodes allows the SVO, which can discharge at very high rates, to be preferentially discharged when high current is needed to charge the capacitors. Over time the extra lithium ions that accumulate in the SVO part of the electrode equalize with the CFx part, so that the lithium ions become distributed equally within both parts of the cathode. The voltage curve starts at about 3.2 V, stays almost flat from about 20% to 50%, and then gradually declines. Figure 6-14 shows a typical discharge curve.20

image Emerging Power Sources

Rechargeable Lithium-Ion Batteries

Rechargeable lithium-ion cells were introduced to the consumer market by the Sony Corporation in 1992. Since that time, lithium-ion technology has been the major focus of research and development investment by many leading battery manufacturers. Lithium-ion batteries exhibit several characteristics that make them highly suitable for implantable medical applications, as follows:

It is not yet clear what future applications will emerge for rechargeable batteries in the cardiac rhythm management arena, but some applications are likely, and substantial patent activity is already occurring. In fact, neurologic spinal cord stimulators powered by rechargeable lithium-ion batteries have been developed by three different device manufacturers and make up the majority of current implants. Lithium-ion batteries are also used to provide temporary power for some left ventricular assist devices (e.g., while patient is bathing). In many applications the time between recharges could be as long as weeks or months.

Possible modes of lithium-ion battery application include the following:

Principles of Operation

The defining feature of a lithium-ion battery is that it contains no metallic lithium. Instead, lithium ions (Li+) are shuttled back and forth between the positive and negative electrodes during charge and discharge, as shown in Figure 6-15. The most common electrode materials are lithium cobalt oxide (LiCoO2) for the positive cathode material and a graphitic carbon to contain the intercalated lithium for the negative anode material. Many alternative materials are being developed and introduced in commercial batteries and will eventually migrate to batteries for implantable medical devices. The general cell construction is similar to that shown for the Li/SVO battery. However, lithium-ion batteries are manufactured in their discharged state (e.g., using LiCoO2 and graphite) and then charged (or “formed”) after the cell is fully assembled.

End of Service Life

Lithium-ion batteries typically exhibit a gradually declining voltage during discharge that can be used as a “gas gauge” to indicate the state of discharge at a given time (Fig. 6-16). Information about the voltage can be telemetered to a patient controller or a monitor to alert the patient of the need to recharge the battery. However, the end of service for a device powered by a lithium-ion battery is not as readily apparent as for one powered by a primary battery. Because the lithium-ion battery slowly loses capacity as a function of both time and the total number of charge/discharge cycles, the patient may eventually experience a reduced interval between recharge sessions becomes too short to be acceptable to the patient. However, because rechargeable batteries can, in principle, provide unlimited energy, the eventual end of service may be determined by the lifetime of some other component of the implanted device.

Capacitors

The ICDs defibrillate the heart by delivering one or more high-energy, high-voltage shocks. The power capability and voltage of the battery alone are not sufficient to accomplish this. High-voltage capacitors are necessary to store and deliver the energy required for these shocks. The use of capacitors has important clinical implications, including delivered energy, device size, charge time, and longevity.

Capacitance

In its simplest form, a capacitor consists of two conductors, separated in space and electrically insulated from each other. When the conductors are charged, each stores an equal and opposite amount of charge. In an ideal capacitor, the amount of charge (Q) on each conductor is proportional to the difference in voltage (V) between the two conductors. The proportionality constant, C, is called the capacitance.

(6-10) image

The simplest model of a capacitor is shown in Figure 6-17, A, in which the plates are separated in a vacuum. The conductors (or electrodes) consist of two parallel plates of area (A) separated by a distance (d). The capacitance, or ability to store charge as a function of voltage, is equal to A/d multiplied by a fundamental constant, ε0, the permittivity of free space, which is related to the energy required to separate charge in a vacuum. The value of the capacitance can be increased by inserting insulating materials, known as dielectrics, between the electrodes. The factor by which these materials increase the capacitance is called the dielectric constant, k, which is the ratio of the permittivity of the material to the permittivity of free space, ε/ε0. A simple capacitor containing a dielectric material is shown in Figure 6-17, B. Various materials are used as dielectrics the properties of which largely determine the properties of the capacitor.

Energy Delivery

During defibrillation, the energy stored in the capacitor is delivered to the heart using an electrical path between the opposing electrodes of the capacitor. This connection allows the separated charge to recombine by traveling through the heart.

When an ideal capacitor is discharged through a constant resistance, R, the voltage decays with time in an exponential manner, as seen in Figure 6-18. For an ideal capacitor discharged to 0 volts, the delivered energy would equal the stored energy. In ICDs the amount of energy delivered from the capacitor is less than the amount stored. One reason is that the therapy delivery is truncated before the capacitor is completely discharged, and the remaining energy is discarded. A truncated waveform is used because it defibrillates the heart more effectively than a waveform that is allowed to decay to 0 V, despite less energy being delivered to the heart. Other inefficiencies associated with the capacitor, device circuit, and delivery system also reduce the amount of stored energy delivered to the heart, as discussed later.

ICD Capacitor Types

The defibrillation capacitors used in past and current ICDs are called electrolytic capacitors, most often based on aluminum or tantalum electrode materials. The metal electrode materials are processed so they have a very large surface area, which allows for a high capacitance. For aluminum electrolytic capacitors, the positive electrode (anode in a capacitor) starts as a thin foil that has been etched to create a large number of tunnels. Figure 6-19 shows a scanning electron micrograph of a cross section of a highly etched anode foil. For tantalum electrolytic capacitors, the anode is made from tantalum metal powder pressed into a porous pellet and heated to a high enough temperature to make the metal particles bond to one another (called sintering) while still remaining porous. For either material, an oxide film is electrochemically grown (called forming) on the exposed surfaces of the metal electrode. The oxide serves as the capacitor dielectric. Aluminum anodes are typically formed to support charging to about 400 V. Two capacitors are connected in series in the ICD to provide sufficient voltage for defibrillation. Tantalum anodes are typically formed to support charging to 175 to 250 V with three or four capacitors connected in series.

The high capacitance, high voltage, and relatively low resistance of aluminum and tantalum electrolytic capacitors provide their high energy density (3-5 J/cc) and quick, efficient energy delivery that make them the capacitors of choice for ICDs.

ICD Capacitor Construction

Early ICD devices used commercially produced, cylindrically wound, aluminum electrolytic capacitors developed for flash photography applications. The need for smaller, thinner capacitors and specialized shapes led ICD manufacturers to develop stacked-plate aluminum electrolytic capacitors and custom tantalum electrolytic capacitors.21,22

Tantalum Electrolytic Capacitor Construction

Tantalum electrolytic capacitors have the same basic elements as aluminum electrolytic capacitors. In tantalum capacitors the anode is made using pressed, sintered, and formed tantalum pellet. The cathode in a tantalum capacitor is typically deposited directly on the inside of the capacitor case, making it the negative terminal of the capacitor. Tantalum capacitors have similar benefits to stacked-plate aluminum capacitors but provide higher energy and simpler construction than aluminum capacitors. Rather than layered anode foils, tantalum capacitors have a single anode pellet. The simple and efficient construction minimizes the volume of materials that do not contribute to energy storage (cathode, separator, encasement), thus maximizing energy density. Tantalum capacitors used in current ICDs have an energy density of 5 J/cc or more. The primary drawback of tantalum capacitors is their mass. Because tantalum is very dense, tantalum capacitors are approximately 50% heavier than aluminum capacitors with equivalent energy. Figure 6-22 shows a cutaway view of a tantalum electrolytic capacitor similar to those used in some current ICDs.

Non-Ideal Behavior in Capacitors

Although the electrolytic capacitors used in ICDs have performance characteristics well suited to the ICD application, their performance does deviate from ideal in ways that can be clinically significant.

Deformation

The non-ideal process that is most apparent is called deformation. As previously explained, the dielectric material in electrolytic capacitors is created by “forming,” immediately after which the dielectric is almost free of defects. Over time, the chemical environment within the capacitor or relaxation of residual stress will cause microscopic imperfections in the oxide film on the anode. When the capacitor is charged to a high voltage after a long period of disuse, additional energy is required to regrow oxide in these areas to heal the defects.23 This process is known as re-formation. The additional energy needed to re-form the dielectric results in longer charge times in ICDs. In a typical aluminum capacitor, 25% or more additional energy (and time) may be required to charge the capacitor if it has been many months since the last charge. The amount of additional energy drops to about 15% for capacitors not charged for about a month. Tantalum capacitors perform similarly, although the rate of deformation may be somewhat slower. Figure 6-23 shows capacitor deformation in typical aluminum capacitors for various charging intervals.

To minimize the clinical effect of deformation, current ICDs incorporate a programmable maintenance routine that automatically charges the capacitor to high voltage to heal the dielectric at intervals of 1 month, 3 months, or 6 months.

Capacitor Failure Modes

Capacitor failure modes depend greatly on the specific conditions of device use. The failure modes most relevant to the ICD application are discussed here.

image Effects of Batteries and Capacitors on Defibrillation Performance

Energy Losses in Defibrillators

The processes of charging the capacitors and discharging the energy through the leads of a cardiac defibrillator have numerous inefficiencies, which result in a substantial disparity between the chemical energy consumed in the battery and the electrical energy delivered to the heart. Besides capacitor deformation, leakage current, and capacitor resistance, as previously discussed, other losses are inherent in the design of the device-charging circuit and leads.

The most significant loss of energy is associated with the battery. Batteries in ICDs are designed to be as small as possible, which means that they tend to be operated near their maximum power capability. An ideal power source operates at maximum power when the load placed on the power source matches the internal resistance of the power source. This well-known concept is often referred to as “impedance matching.” In terms of energy efficiency, it means that when a power source is operating at maximum power, only half of the total energy consumed is delivered to the external load. The remainder of the energy is dissipated as heat inside the ICD. Considering all these contributions, the overall efficiency of the battery/charging-circuit/capacitor/lead system for current ICDs is less than 50%. To put this energy consumption in clinical perspective, the energy content of a typical ICD battery is on the order of 15,000 J. A system operating at 50% efficiency would consume 70 J from the battery, or about 0.5% of the total energy. This equates to about 10 to 15 days of longevity reduction for each 35-J shock delivered.

Clinical Implications of Design

When comparing the performance of ICDs, many principal parameters are interrelated, and optimizing one may degrade another. The clinician should be aware of these issues to develop realistic expectations for device performance. Four principal characteristics of an ICD interact, primarily because of the battery and the defibrillation capacitors: size, longevity, charge time, and defibrillation energy. Smaller ICDs may be desirable, but all else being equal, small size trades off longevity, charge time, and maximum shock energy. Higher maximum shock energy will extend charge time and reduce longevity. The ICD manufacturer must strike an appropriate balance between ICD volume and clinically important parameters such as longevity, charge time, and maximum shock energy.

The clinician should also be aware that charge times are generally specified assuming formed capacitors. Since deformed capacitors consume additional energy in charging, charge times for devices that have not been recently charged can be up to 25% longer for the first defibrillation therapy delivered.

Specific device use conditions also have a significant impact on observed device performance. As discussed earlier, the energy removed from the battery during each charge of the output capacitor represents a significant fraction of its total energy, on the order of 0.5% to 1.0%. Thus the longevity of a defibrillator depends greatly on the frequency of the shock therapy. This is further complicated by single-, dual-, or triple-chamber pacing conditions. For example, a device used only as a defibrillator that delivers few therapeutic shocks may last more than 13 years, whereas the same device may only last 3 to 5 years if implanted in a patient who requires significant triple-chamber pacing or if many shocks are delivered. Longevity differences can be a factor of three or greater depending on how the device is used.

References

1 Brennen KR, Fester KE, Owens BB, Untereker DF. Pacemaker battery capacity: a consideration of the manufacturer’s problem. Proceedings of the VIth World Symposium on Cardiac Pacing. Montreal: Pacesymp; 1979.

2 Brennen KR, Fester KE, Owens BB, Untereker DF. A capacity rating system for cardiac pacemaker batteries. J Power Sources. 1980;5:25.

3 Broadhead J. Electrochemical principles and reactions. In Linden D, editor: Handbook of batteries and fuel cells, ed 2, New York: McGraw-Hill, 1994.

4 Holmes CF. An approach to the reliability of implantable lithium batteries. J Power Sources. 1989;26:185.

5 Schmidt CL, Skarstad PM. Impedance behavior in lithium iodine batteries. In: Abraham KM, Solomon M, editors. Proceedings of the Symposium on Primary and Secondary Lithium Batteries, PV91 3. Electrochemical Society; 1991:75-85.

6 Schmidt CL, Skarstad PM. Development of a physically based model for the lithium iodine battery. In: Keily T, Baxter BW, editors. Power sources 13. Leatherhead, England: International Power Sources Committee; 1991:347-361.

7 Untereker DF, Owens BB. Microcalorimetry: a tool for the assessment of self-discharge processes in batteries. Gaithersburg, Md: National Bureau of Standards Workshop; 1977.

8 Untereker DF. The use of a microcalorimeter for analysis of load dependent processes occurring in a primary battery. J Electrochem Soc. 1978;125:1907.

9 Owens BB, editor. Batteries for implantable biomedical devices. New York: Plenum, 1986.

10 Antonioli G, Baggioni F, Consiglio F, et al. Stimulatore cardiaco implantible con nuova battaria a sato solido al litio. Minerva Med. 1973;64:2298.

11 Weiss DJ, Cretzmeyer JW, Crespi AM, et al. Electrochemical cells with end-of-service indicator. US Patent. 1993;5:180. 642

12 Schmidt CL, Skarstad PM. The future of lithium and lithium-ion batteries in implantable medical devices. J Power Sources. 2001;97/98:742-746.

13 Takeuchi ES, Quattrini JP. Batteries for implantable defibrillators. Med Electronics. 1989;119:114-117.

14 Liang CC, Bolster E, Murphy RM: Metal oxide cathode material for high energy density batteries. US Patents 4:310, 609_1982 and 4,391,729_1983.

15 Holmes CF, Keister P, Takeuchi E. High rate lithium solid cathode battery for implantable medical devices. Prog Batteries Solar Cells. 1987;6:64.

16 Crespi AM. Silver vanadium oxide cathode material and method of preparation. US Patent. 1993;5:221. 453

17 Crespi A, Schmidt C, Norton J, et al. Modeling and characteristics of the resistance of lithium/SVO batteries for implantable cardioverter defibrillators. J Electrochem Soc.. 2001;148:A30-A37.

18 Medtronic. Tachyarrhythmia technical concept paper. Vol V, No 1. Marquis ICD Battery Technology.

19 Root MJ. Lithium-manganese dioxide cells for implantable defibrillator devices: discharge voltage models. J Power Sources 2008. 2009;12:083. doi:10.1016/j.jpowsour

20 Gan H, Rubino RS, Takeuchi ES. Dual-chemistry cathode system for high-rate pulse applications. J Power Sources. 2005;146:101-106.

21 Strange TF, Graham TV. Beyond photoflash; development of a polyanode capacitor. CARTS 2000, Huntington Beach, Calif. Proceedings of the 20th Capacitor and Resistor Technology Symposium. 16-21:2000.

22 Breyen MD, Rorvick AW, Skarstad PM. Efficiently packaged aluminum electrolytic capacitors for implantable cardioverter-defibrillators. CARTS 2002, New Orleans. Proceedings of the 22nd Capacitor and Resistor Technology Symposium. 197-202:2002.

23 Norton J, Anderson C. Energy management in aluminum electrolytic capacitors. CARTS 2003, Scottsdale, Ariz. Proceedings of the 23rd Capacitor and Resistor Technology Symposium. 269-277:2003.